Company & Sponsor Intelligence

Peking University

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials4

Recruiting1

Completed1

Countries1

Therapeutic footprint

adhddepression

Indexed studies

NCT07458100The STEP-MIED Trial: Digital Stepped-Care for Emotional Disorders
depression · ChinaNA

NCT04684277Internet-Based Interventions for MDD
depression · ChinaNA

NCT05361330A Multicenter Clinical Study on Shuganjieyu Capsule Combined With Fluoxetine in the Treatment of Depression
depression · ChinaNA

NCT01339286Associated Genes With Atomoxetine Response in Attention Deficit Hyperactivity Disorder (ADHD)
adhd · ChinaPHASE4

Intelligence layer updated: 2026-10-29 06:17:44.639239+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →